APA

Costagliola C., Morescalchi F., Duse S., Romano D., Mazza G., Parmeggiani F., Bartollino S. & Semeraro F. (20190904). Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an update. : Expert opinion on drug safety.

Chicago

Costagliola Ciro, Morescalchi Francesco, Duse Sarah, Romano Davide, Mazza Giuseppina, Parmeggiani Francesco, Bartollino Silvia and Semeraro Francesco. 20190904. Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an update. : Expert opinion on drug safety.

Harvard

Costagliola C., Morescalchi F., Duse S., Romano D., Mazza G., Parmeggiani F., Bartollino S. and Semeraro F. (20190904). Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an update. : Expert opinion on drug safety.

MLA

Costagliola Ciro, Morescalchi Francesco, Duse Sarah, Romano Davide, Mazza Giuseppina, Parmeggiani Francesco, Bartollino Silvia and Semeraro Francesco. Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an update. : Expert opinion on drug safety. 20190904.